Showing results (461-470 of 655) with videos related to

Sort By:
Pageof 66
British Journal of Clinical Pharmacology|October 9, 2015
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinomaAnna Maria J Thijs, Cees J Tack, Winette T A van der Graaf, et al.
The Netherlands Journal of Medicine|August 12, 2005
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivityL J H van Tits, E Arioglu-Oral, C G J Sweep, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2007
Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux diseaseJ M Conchillo, M P Schwartz, M Selimah, et al.
Clinical Science (London, England : 1979)|March 1, 2002
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetesE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study GroupJ M Gwaltney, S Savolainen, P Rivas, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Neurogastroenterology and Motility|May 22, 2016
The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in manE Scarpellini, E Deloose, R Vos, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrineBastiaan E De Galan, Cees J Tack, Jacques J Willemsen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructose- compared to glucose-fed micePatricia M Nunes, Alan J Wright, Andor Veltien, et al.
Clinical Pharmacology and Therapeutics|November 4, 2011
Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profileH Jacobs, G H Koek, R Peters, et al.
Pageof 66